Home
Company Profile
SURGICAL ONCOLOGY
HIPEC – Hyperthermic IntraPeritoneal Chemotherapy
Isolated Organ Perfusion
Performer HT – Hyperthermic Perfusion
Publications
Congresses
Links
PRODUCTS
Performer 3
Performer HT
SERVICES
Perfusion service
MULTIMEDIA
F.A.Q.
Contacts
LANGUAGE
Deutsch
Français
Español
Italiano
Cost-effectiveness of hyperthermic intraperitoneal chemotherapy (HIPEC) at interval debulking of epithelial ovarian cancer following neoadjuvant chemotherapy
Stephanie L.Lima, Laura J.Havrilesky, Ashraf S.Habib, Angeles Alvarez Secord
Prev
Next